Search for: "Gene Quinn" Results 1 - 20 of 437
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Sep 2021, 9:55 am by Patent Docs
Xiaofan Chen of AWA Asia and Gene Quinn of IPWatchdog, Inc. will discuss China's new Patent Law -- the first major update to the law since 2008, which entered into force on June 1, 2021, and which brings substantial changes, including the creation of a patent linkage system, introduces an open license system, improves protection for industrial designs as well as several new provisions directed towards pharmaceuticals, and strengthens patent enforcement.... [read post]
25 Sep 2021, 9:01 pm by Patent Docs
Gene Quinn of IPWatchdog, Inc.; Andrew Grossman of BakerHostetler; Paul Kamenar, Senior Fellow of the Administrative Conference of the United States; and independent inventor Gilbert Hyatt will discuss Mr. [read post]
18 Sep 2021, 8:44 pm by Patent Docs
Gene Quinn of IPWatchdog, Inc., Christopher Patrick of Baker Botts, Jennifer Russell of Surgalign Spine Technologies, Inc., and Gabe Sukman of ClearstoneIP will discuss where focus should be placed in order to maximize value and insight in patent clearance in the wake of a resurgence in large scale patent damage awards. [read post]
15 Sep 2021, 2:37 pm by IPWatchdog
” Delrahim recalled during a Luncheon Fireside Chat with IPWatchdog Founder and CEO Gene Quinn that, 20 years ago, when he was detailed to the Office of the U.S. [read post]
15 Sep 2021, 2:37 pm by Stone Law, P.C.
” Delrahim recalled during a Luncheon Fireside Chat with IPWatchdog Founder and CEO Gene Quinn that, 20 years ago, when he was detailed to the Office of the U.S. [read post]
13 Jul 2021, 11:43 pm by Annsley Merelle Ward
These include ethical issues that arise in daily practice, insights to help them handle these issues and issues related to diversity and inclusion.IPWatchdog founder Gene Quinn and John White, both well-known instructors of the Practicing Law Institute’s patent bar review course, provided a primer on ethics while practicing before the PTO. [read post]
12 Jul 2021, 7:58 pm by Patent Docs
Gene Quinn of IPWatchdog, Inc. and Megan McLoughlin of LexisNexis IP will discuss the processes and policies driving the U.S. [read post]
12 Jul 2021, 7:58 pm by Patent Docs
Gene Quinn of IPWatchdog, Inc. and Megan McLoughlin of LexisNexis IP will discuss the processes and policies driving the U.S. [read post]
10 Jul 2021, 7:24 pm by Patent Docs
Gene Quinn of IPWatchdog, Inc. will moderate a panel consisting of Angela Grayson, Founder and Principal Member, PRECIPICE; Mary Jutten, CEO Traklight, Inc and Juetten Law, P.C.; Efrat Kasznik, Founder and Founder & President, Foresight Valuation Group, LLC; and Renée C. [read post]
10 Jul 2021, 7:24 pm by Patent Docs
Gene Quinn of IPWatchdog, Inc. will moderate a panel consisting of Angela Grayson, Founder and Principal Member, PRECIPICE; Mary Jutten, CEO Traklight, Inc and Juetten Law, P.C.; Efrat Kasznik, Founder and Founder & President, Foresight Valuation Group, LLC; and Renée C. [read post]
19 Jun 2021, 8:53 pm by Patent Docs
Jerzy Klosin of The Dow Chemical Company; Christine Goddard of Fish & Richardson; Matthew McBride of CAS; and Gene Quinn of IPWatchdog, Inc. will discuss IP, R&D, and facilitating innovation to streamline commercialization. [read post]
12 Jun 2021, 8:07 pm by Patent Docs
Brian Arthur Pomper of Akin Gump; Melissa Brand, Assistant General Counsel, IP, Biotechnology Innovation Organization (BIO); Sarbani Chattopadhyay of LexisNexis; and Gene Quinn of IPWatchdog will discuss the petition by South Africa and India at the World Trade Organization (WTO) to waive most of the protections in the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement, and whether this is helping or hurting innovation. [read post]
22 May 2021, 8:55 pm by Patent Docs
Carla Mouta-Bellum of Arrigo, Lee, Guttman & Mouta-Bellum, LLP; Rachel Elsby of Akin Gump Strauss Hauer & Feld, LLP; and Gene Quinn of IPWatchdog, Inc. will discuss ongoing research and development, patenting activities and pitfalls, as well as patent enforcement and infringement in cancer immunotherapy. [read post]
15 May 2021, 8:45 pm by Patent Docs
Eyal Barash of Barash Law and Gene Quinn of IPWatchdog, Inc. will discuss solid-form patents in the pharmaceutical industry, including prosecution, claim drafting, novelty, obviousness, enablement, non-species claims in a crystalline-form context, claim interpretation, and proving infringement. [read post]
15 May 2021, 8:43 pm by Patent Docs
David Donoghue of Holland & Knight, Evan McAlpine and Ryan Hynes of Relativity, and Gene Quinn of IPWatchdog, Inc. will discuss the proper balance between defensive monitoring and monitoring to identify white space and other specific examples of how landscaping analysis can be useful to proactively provide value-add to business development strategies, and will also address what to do when litigation is approaching. [read post]
25 Apr 2021, 9:06 pm by Patent Docs
Gene Quinn of IPWatchdog, Inc. will moderate a panel consisting of Kate Gaudry of Kilpatrick Townsend & Stockton LLP; Ryan Abbott, Professor of Law and Health Sciences at the University of Surrey School of Law, and Adjunct Assistant Professor of Medicine at the David Geffen School of Medicine at UCLA; and Richard Frank of Siemens Healthineers. [read post]
25 Apr 2021, 9:02 pm by Patent Docs
Gene Quinn of IPWatchdog, Inc. will moderate a panel consisting of Carlo Cotrone of Techtronic Industries North America (TTI) and Jim Durkin of IP.com. [read post]
22 Apr 2021, 1:15 pm by Eileen McDermott
Court of Appeals for the Federal Circuit Chief Judge Paul Michel, Meredith Addy of AddyHart, and IPWatchdog Founder and CEO Gene Quinn about the many obstacles facing patentees today in light of the Patent Trial and Appeal Board (PTAB) and an overburdened Federal Circuit. [read post]
22 Apr 2021, 1:15 pm by Stone Law, P.C.
Court of Appeals for the Federal Circuit Chief Judge Paul Michel, Meredith Addy of AddyHart, and IPWatchdog Founder and CEO Gene Quinn about the many obstacles facing patentees today in light of the Patent Trial and Appeal Board (PTAB) and an overburdened Federal Circuit. [read post]